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Abstract Death domain containing members of the tumor
necrosis factor receptor (TNFR) superfamily can induce
apoptosis or cell activation. However, the mechanisms by which
these opposing programs are selected remain unclear. Fre-
quently, NF-UB activation conveys protection against cell death.
We show that the serine/threonine kinase RIP that is required for
TNF-induced NF-UB activation is processed by caspase-8 into a
dominant-negative (DN) fragment during death receptor-induced
apoptosis, thereby leading to a blockade of NF-UB-mediated
anti-apoptotic signals. Our results suggest that cleavage of RIP
is part of an amplification loop which is triggered by Fas and
most likely by other death receptors.
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1. Introduction
Tumor necrosis factor (TNF) binds two distinct cell surface
receptors, TNFR1 and TNFR2 [1]. TNFR1 is thought to be
the predominant receptor that signals both cytotoxic and in-
£ammatory responses. The intracellular mediators of the TNF
response include proteins characterized by ‘death domains’
such as TRADD and FADD/MORT1 [2]. These proteins
bind a conserved 80 amino acid region found in the cytoplas-
mic domain of TNFR1 receptor family members and serve as
adaptors to assemble a signaling complex that leads to apop-
tosis. FADD initiates apoptosis by mediating the activation of
caspase-8 [2]. Another group of receptor-interacting molecules
includes the TNF receptor-associated factors (TRAFs) and
the serine/threonine kinase RIP. Upon TNFR1 trimerization,
TNFR1 binds TRADD that recruits the RIP and TRAF2
[16]. RIP appears to mediate NF-UB activation [3,4].
Although RIP is an active serine/threonine kinase, the func-
tional signi¢cance of its kinase activity is still unknown.
In response to TNF and Fas ligand treatment, NF-UB acti-
vation protects cells against TNF-induced apoptosis [5^9].
Thus, it has been proposed that the balance between life
and death is regulated by NF-UB. Since RIP is a key e¡ector
in the pathway that transduces TNF signal to NF-UB activa-
tion, it was interesting to note that RIP is processed by re-
ceptors that signal apoptosis via the activation of caspase-8,
resulting in the formation of a dominant-negative (DN) form
impairing NF-UB signal transduction. Thus, the cleavage of
RIP abolishes the induction of anti-apoptosis factors, leading
to the ampli¢cation of death signals and rapid apoptosis.
2. Materials and methods
2.1. Antibodies/reagent/cell lines
Monoclonal antibodies used in Western blotting include: anti-Flag
antibody (Kodak), anti-caspase-3 and RIP antibodies (Transduction
Laboratories), anti-caspase-8 antibody (PharMingen). Human re-
combinant Fas ligand and caspase inhibitors were obtained from
Alexis, Switzerland. Jurkat lymphoma cells were maintained in
RPMI 1640 (Life Sciences, Basel, Switzerland) supplemented with
10% FCS and antibiotics.
2.2. Expression vectors
Expression vectors for RIP (559^671) and VSV-RIP were generated
by PCR ampli¢cation/PCR-based mutagenesis, and subcloned into
pCR3-derived vectors (Invitrogen) conferring an N-terminal and/or
C-terminal Flag-tag. v-FLIP expression vectors have been described
[10].
2.3. Transfection
293T Cells were seeded at 4U105 in a 3.5 cm plate and transfected
by the calcium phosphate precipitation method as previously de-
scribed [11]. The luciferase assays have been described [11].
3. Results and discussion
3.1. RIP is rapidly cleaved by caspases during Fas-induced
apoptosis
As RIP is one of the molecules whose de¢ciency was dem-
onstrated to completely abrogate TNF-induced NF-UB acti-
vation [3,4], we considered RIP as an ideal target. Indeed,
when BJAB, Raji and Jurkat T cells were killed by FasL,
complete conversion of the 74 kDa protein into a 38 kDa
fragment was detected by Western blot analysis (Fig. 1A
and data not shown). Since the epitope recognized by the
monoclonal anti-RIP antibody lies within the death domain,
cleavage had to occur between the kinase domain and the
intermediary domain (Fig. 1B). When Asp-324 was mutated
to Glu, cleavage of RIP was abolished, whereas the mutation
of two other putative caspase cleavage sites (D300E and
D418E) had no e¡ect (Fig. 2A). The preceding sequence of
this cleavage site is (321)LQLD(324) which correlates with the
preferred cleavage motif of caspase-8 (LXXD). RIP cleavage
was indeed inhibited by the caspase-8 inhibitors FLIP (Fig.
2B) and zVAD, IETD-fmk but to a lesser extent by DEVD-
fmk and YVAD-fmk (Fig. 2C), suggesting that RIP process-
ing is caused by caspase-8.
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Similar to processed TRAF1 (see accompanying paper), the
C-terminal fragment of RIP generated during apoptosis acted
as a DN inhibitor of NF-UB activation (Fig. 3). Compared to
the death domain of RIP (RIP 559^671), RIP 324^671 was
slightly less potent, but was still capable of reducing TNFK-
induced NF-UB activation by more than 70%.
3.2. Activation of a pro-apoptotic ampli¢cation loop during
death receptor-mediated apoptosis
While the exact role of RIP in TNF-induced NF-UB acti-
vation is still unknown, it is clear that its absence blocks NF-
UB signaling as cell lines or primary cells lacking RIP are
unable to activate NF-UB in response to TNF [3,4]. We found
rapid cleavage of RIP into two major fragments when apop-
tosis was induced by FasL. Cleavage occurred after Asp-324,
in agreement with a very recent publication [12].
As NF-UB activation is part of the response of several death
receptors (TNFR1, TRAIL-R1/R2, TRAMP/DR3 and possi-
bly Fas) [2], con£icting signals can be triggered that on one
hand activate gene transcription resulting in an anti-apoptotic
response and cell survival, and on the other hand induce cell
death (Fig. 4). The pathway which is initially chosen may
depend on the presence or absence of low constitutive NF-
UB activation, caused by signals emanating from growth fac-
tor receptors, adhesion receptors or others. We observed that
low constitutive activation of NF-UB was su⁄cient to protect
HT1080 cells against TNF, but not FasL and TRAIL-induced
cell death (see accompanying paper). Massive NF-UB activa-
tion was necessary to render these cells resistant to the latter
two death ligands. Once the NF-UB pathway is selected in
response to TNF, a self-amplifying loop is initiated which
further augments NF-UB signals, thus further de£ecting the
pro-apoptotic signal toward survival (Fig. 4).
A di¡erent scenario may be envisaged if the pro-apoptotic
response is chosen in response to death ligands, probably
under conditions of low NF-UB activity. A hallmark in the
induction of apoptosis is the activation of the caspase cascade.
Some of the caspase-mediated cleavage products are pro-
apoptotic proteins, resulting in self-ampli¢cation and acceler-
ation of cell death. Examples are the cleavage of BID [13,14],
MEKK1 [15], ICAD [16] and PKC delta [17]. Acceleration of
cell death, however, is also achieved by blocking the activity
of inhibitors of apoptosis. Caspase-3-dependent Bcl-2 cleav-
Fig. 1. RIP is processed during apoptosis. (A) Jurkat T cells were
treated with cross-linked sFasL (300 ng/ml) for the indicated times.
Processing of RIP, caspase-8 and caspase-3 was assessed by Western
blot analysis of whole cell lysates using the appropriate antibodies.
(B) Schematic representation of the structure of RIP. The N-termi-
nal kinase domain is followed by a short coiled-coil region (stippled
box) which is followed by a death domain (DD). The caspase cleav-
age site is indicated.
Fig. 2. Cleavage of FLIP occurs at Asp-324 most likely by caspase-
8. (A) FlagRIP and the indicated mutants were overexpressed (2 Wg
plasmid) in 293T cells and processing was analyzed by immunoblot-
ting using an antibody detecting an epitope within the DD of RIP.
(B) Inhibition of FlagRIP processing by v-FLIP. Increasing
amounts of v-FLIP were co-transfected with FlagRIP expression
plasmid (2 Wg) into 293T cells and processing was analyzed by
Western blot using an anti-Flag antibody. (C) FlagRIP-transfected
293T cells were treated with cross-linked FasL for 12 h in the pres-
ence of various caspase inhibitors (50 WM unless indicated). Whole
cell lysates were analyzed by immunoblotting using an anti-RIP
antibody.
Fig. 3. Transcription factor NF-UB is blocked by the C-terminal
RIP cleavage product. 293T Cells were transfected with VSV-RIP
(324^671) or DN forms of other signaling molecules. 24 h after
transfection, cells were treated with TNF (10 ng/ml) for 6 h and
NF-UB activity was measured.
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age is observed during apoptosis, converting Bcl-2 into an
inducer of apoptosis [18]. Interestingly, both RIP and
TRAF1 (see accompanying paper) conversion do not lead to
their inactivation but rather to the formation of DN versions.
We found that the C-terminal fragments of TRAF1 and RIP
which are generated during apoptosis both interfere with
TNF-induced activation of NF-UB. Thus, cleavage of only a
fraction of TRAF1 and RIP can result in a complete blockade
of the NF-UB-dependent anti-apoptotic pathway (Fig. 4).
Recent results show that NF-UB inactivation is also used to
amplify pro-apoptotic signals that are triggered upon growth
factor withdrawal [7]. In this case, inactivation occurs further
downstream and is achieved by the cleavage of the NF-UB/Rel
A subunit of NF-UB by caspase-3 and/or -6. NF-UB/Rel A
processing may be complementary to the TRAF1/RIP inacti-
vation pathway.
There is substantial cross-talk between pro-apoptotic and
survival pathways. Our results suggest that cleavage of
TRAF1 and RIP is part of an ampli¢cation loop which is
triggered by Fas and most likely by other death receptors
which trigger caspase-8 (or -10) activation. As a result,
cross-sensitization between di¡erent pro-apoptotic signaling
pathways occurs. For example, weak Fas signals will sensitize
cells to signals by TNF and TRAIL. Considering that the NF-
UB response leads to the protection against apoptosis by many
di¡erent apoptotic stimuli, cross-sensitization to other stimuli
such as those triggered by mitochondria and vice versa is
likely to occur. Interestingly, we found that detachment of
adherent cells leads to a highly increased sensitivity to
FasL-induced cell death (unpublished data). Thus, the simul-
taneous inactivation of anti-apoptotic pathways controlled by
NF-UB will ultimately result in a rapid cell death, thus avoid-
ing the situation that a cell is half dead and half alive.
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Fig. 4. Model of caspase-induced inactivation of NF-UB-mediated protection from apoptosis. TNF- and to a lesser extend FasL-induced death
signals (1) are antagonized by proteins such as IAP-1, IAP-2, TRAF1, TRAF2, which, if present at the time of signal initiation, deviate the
pro-apoptotic signal into NF-UB activation signals (2). The concentration of these anti-apoptotic proteins is gradually increased as their expres-
sion is under the control of the NF-UB transcription factor (anti-apoptotic ampli¢cation loop). When these NF-UB-dependent anti-apoptotic
proteins are absent or at low concentration during signal initiation, death signals propagate, resulting in the activation of caspases and the sub-
sequent cleavage of anti-apoptotic proteins (TRAF1, RIP). This allows other pro-apoptotic pathways (other death receptors, mitochondrial
pathway) to become more active, leading to an enormous acceleration of cell death (pro-apoptotic ampli¢cation loop).
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